Eucalyptol carries the IUPAC name 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane and the molecular formula C₁₀H₁₈O. It is classed as a monoterpenoid ether , specifically a cyclic ether , rather than a simple hydrocarbon terpene, which gives it a notably higher boiling point (176 °C) and greater water solubility than many of its terpene relatives. At room temperature it is a colourless, mobile liquid with a cooling, slightly sweet, camphor-like scent that has made it a longstanding reference standard in aroma science.
In nature, eucalyptol is the dominant volatile constituent of the essential oils distilled from many Eucalyptus species , particularly Eucalyptus globulus and Eucalyptus radiata; where it can comprise 60–90% of the total oil fraction. Beyond the genus that gave it its common name, it also occurs in significant concentrations in Melaleuca species, rosemary (Salvia rosmarinus), common sage, cardamom (Elettaria cardamomum), laurel (Laurus nobilis), and cannabis (Cannabis sativa), where it is a minor but consistently detected terpene. Biosynthetically, it is derived from geranyl pyrophosphate via the monoterpene pathway.
From a chemistry standpoint, eucalyptol is of interest for its stability and its role as a solvent and penetration enhancer in formulation science, properties studied independently of any therapeutic outcome. In cannabis phytochemistry, it is one of the monoterpenoid constituents sometimes examined when researchers map the full terpene profile of a given cultivar or extract. Preliminary in-vitro and animal studies have explored its chemical interactions at a cellular level; however, these findings remain early-stage, have not been confirmed by large-scale controlled human trials, and cannot be interpreted as evidence that eucalyptol treats, prevents, or relieves any condition in humans.
Regulatory note: In Australia, essential oils and botanical extracts containing eucalyptol are subject to assessment by the Therapeutic Goods Administration (TGA) when presented with therapeutic claims. Classification under the Poisons Standard (the Standard for the Uniform Scheduling of Medicines and Poisons) depends on concentration, intended use, and product category. Researchers and formulators should consult current TGA scheduling guidance before making any represented use of eucalyptol-containing preparations.
Sources: